Thioridazine

DRUG5 trials

Conditions

Acute Myeloid LeukemiaAnxiety DisordersDementiaDepressionPsychosomatic DisordersSchizoaffective DisordersSchizophreniaSchizophrenia and Disorders With Psychotic Features

Phase 1

Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia

CompletedNCT02096289

Ontario Clinical Oncology Group (OCOG)Acute Myeloid Leukemia

Start: 2014-07-31End: 2016-09-30Updated: 2016-12-07

Phase 2

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

Not yet recruitingCTIS2024-519778-38-00

Fundacion Para La Gestion De La Investigacion En Salud De SevillaSchizophrenia spectrum disorders, squizophrenia

Target: 37Updated: 2025-03-06

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Phase 4

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

CompletedNCT02307396

Technical University of MunichSchizoaffective Disorders, Schizophrenia, Schizophrenia and Disorders With Psychotic Features

Start: 2015-02-01End: 2016-06-22Updated: 2018-10-11

Unknown Phase

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

CompletedNCT02600741

Janssen Scientific Affairs, LLCSchizophrenia

Start: 2015-07-24End: 2018-07-05Updated: 2019-01-23

JMIR Mental Health2022-04-1520 citations

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial

European Archives of Psychiatry and Clinical Neuroscience2020-02-1537 citations

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.

2018-08-0132 citations

SA105. Characteristics of Patients With Recent-Onset Schizophrenia and Their Caregivers: Is There a Correlation With Caregiver Burden?

Schizophrenia Bulletin2017-03-01